Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Neuronal Excitability

Acute Effect of Pore-Forming Clostridium perfringens ε-Toxin on Compound Action Potentials of Optic Nerve of Mouse

Mercè Cases, Artur Llobet, Beatrice Terni, Inmaculada Gómez de Aranda, Marta Blanch, Briain Doohan, Alexander Revill, Angus M. Brown, Juan Blasi and Carles Solsona
eNeuro 31 July 2017, 4 (4) ENEURO.0051-17.2017; https://doi.org/10.1523/ENEURO.0051-17.2017
Mercè Cases
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mercè Cases
Artur Llobet
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Artur Llobet
Beatrice Terni
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inmaculada Gómez de Aranda
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Blanch
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Briain Doohan
4School of Biomedical Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Briain Doohan
Alexander Revill
4School of Biomedical Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Revill
Angus M. Brown
4School of Biomedical Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom
5Department of Neurology, University of Washington, Seattle, WA 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Blasi
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carles Solsona
1Laboratory of Cellular and Molecular Neurobiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Hospitalet de Llobregat, Barcelona 08907, Spain
2Institut d’Investigació Biomèdica de Bellvitge - Biomedical Research Institute of Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona 08907, Spain
3Institute of Neurosciences, University of Barcelona, Barcelona 08035, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carles Solsona
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Recording CAPs from mouse optic nerve. A, Set-up diagram, the signal is generated with a stimulator and conveyed into the optic nerve through a suction electrode, then recorded using a second suction electrode and send to the amplifier. At the same time, the recording chamber is perfused with Locke solution, which recirculates to get aerated in carbogen every turn. O.N., optic nerve. B, Time line of experiment. The time was set at 0 once the ε-toxin is added to the recording chamber. Three train stimulations of 100 Hz that lasted for 200 ms were applied to the optic nerve: one before the addition of the ε-toxin (t-5), 50 min later (t50), and a last, 80 min (t80). Before ε-toxin addition, the optic nerve is let 30 min to stabilize to the set-up and Locke solution. C, Settings for CAPs analysis. The axes were placed to calculate individually the amplitude and area of the CAP. C1 and C2 are the axes set at the beginning and at the end of the CAP, respectively. The red line is set at the base level. l determines the maximum amplitude of the CAP. D, CAPs elicited at low-frequency stimulation (0.03 Hz) in control conditions before and after adding 50 µl of PBS (vehicle). At -5 min (black), minute 50 (blue), and 85 min (red). E, In ε-toxin condition, examples of CAPs at the same given times. ε-toxin was added dissolved in PBS. Scale bars are represented in each panel. Stimulus artifact was eliminated manually. Differences in shape and amplitudes of initial CAPs in D, E (black) are not related to the action of the ε-toxin, they represent the variability of recording CAPs of different animals.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    ATP release of the optic nerve on ε-toxin exposure. A, Difference of light emission of ATP when optic nerves were treated with ε-toxin (black) or prototoxin (gray). Orange arrow indicates when ε-toxin is added and gray arrow when prototoxin is added. B, Relative increase of light due to the release of ATP induced by ε-toxin (n = 4), mean values ± SEM in black. C, Light emitted indicating ATP is released by the optic nerves once the ε-toxin is applied (orange arrow), ATP is also released when 500 µl of ultrapure water (mQ) was added (blue arrow) and with Triton X-100 at 0.02% (green arrow). Scale bar represented in each panel. AU, arbitrary units; NAU, normalized arbitrary units.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Time-course changes of the CAPs elicited at low frequency (0.03 Hz). Comparison of normalized peak amplitude (A), peak area (B), and time to peak (C) in control (black) and ε-toxin (red) conditions during 125 min. Normalization was done comparing the mean of the last nine CAPs before adding ε-toxin. Mean value ± SEM of control conditions (n = 7) and ε-toxin conditions (n = 11) are shown. Arrows represent when the vehicle (gray) or ε-toxin (orange) was added. After 115 min, 3,4-DAP is added to block potassium voltage-dependent channels present in the juxtaparanode. In nontoxin (D) and ε-toxin (E) conditions, the CAP before the addition of 3,4-DAP (black) and the CAP once 3,4-DAP is applied (purple). Scale bar represented in each panel. F, Comparison of the area increment once 3,4-DAP is applied in control (blue, n = 4) and ε-toxin conditions (red, n = 11). Mean values ± SEM represented.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Analysis of CAPs elicited at high frequency (100 Hz). A–D, The individual CAPs activated during the 200 ms train were synchronized at the time of delivering the stimulus pulse, showing an overall decrease. Representation of the CAP at the beginning of the train (black) to intermediate stages (light blue) and at the end of the train (dark blue) in control conditions at -5 min (t-5; A) and at 80 min (t80; B); gray traces correspond to the rest of CAPs. C, D, Trains before (t-5) and after adding (t80) the ε-toxin. Red traces correspond to the last CAP recorded in the train. In some traces, small transient spikes were recorded and are related to the interference of the peristaltic pump used for perfusion. Stimulus artifact was not removed. E–H, Overall representation of the CAPs elicited by the 100 Hz stimulation in control conditions, to which only vehicle was added, at (E) t-5 and (F) t80. CAPs elicited by the 100 Hz stimulation in ε-toxin conditions at t-5 (G) and t80 (H) after the adding the ε-toxin. Stimulus artifact was eliminated in E–H. I, J, Fractional decrease of peak amplitude in control conditions and with the treatment of ε-toxin at the three different train stimulations: t-5, t50, and t80. I, Control conditions. J, ε-toxin condition. Fractional decrease of the amplitude reflects the change of the amplitude of each of the 20 CAPs with respect to the first peak recorded when starting the train. Statistical significances are indicated by a number on the significance Table 1. K, L, Fractional decrease of peak area in control conditions and with the treatment of ε-toxin at the three different train stimulations: -5, 50, and 80 min. K, Control condition. L, ε-Toxin condition. Statistical significances are indicated by a number on the significance Table 2. M, N, Fractional variation of latency in control conditions and with the treatment of ε-toxin at the three different train stimulations t-5, t50, and t80. M, Control conditions. N, ε-Toxin condition. I–N, Data are presented as mean values ± SEM; control (n = 7) and ε-toxin (n = 11).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Computer simulation on a single myelinated fiber with the dimensions of the mouse optic nerve. A, Equivalent circuit of the model corpus callosum axon, which has been adapted from existing models (Richardson et al., 2000; Devaux and Gow, 2008; Kolaric et al., 2013). The axon is divided into two regions, the node and internodal (INR). Nodal membrane potential is represented by Ex and intermodal potential by Epas. The nodal region expresses voltage-dependent conductances, as well as leak current (gax) and capacitance (Cax). The axolemma underlying the myelin also has these properties (gax and Cax), but the myelin contributes an additional resistive (gmyl) and capacitative barrier (Cmyl). The passive current across the membrane is the sum of gmyl and gax. Axon resistance (Ra) is constant throughout the model. Effect of the increasing gmyl on simulated action potentials during 100 Hz train. B, Nineteen action potentials elicited in a 2 nA pulses train stimulation of 200 ms as represented above. In black, are action potentials of control conditions, with normal conductance (2 × 10−5 S/cm2) and in red, an increase of magnitude by 10 in conductance (2 × 10−4 S/cm2). C, Representation of the fractional decrease of the peak amplitude of the 2-nA 100 Hz train stimuli at a different myelin conductance. Control conditions, 2 × 10−5 S/cm2 (black), 2.2 × 10−5 S/cm2 (gray), 2.5 × 10−5 S/cm2(purple), 3 × 10−5 S/cm2 (yellow), 4 × 10−5 S/cm2 (fuchsia), 5 × 10−5 S/cm2 (blue), and 2 × 10−4 S/cm2 (red). D, Linear relationship between the increase of conductance of a single internode and the estimated number of molecules of the ε-toxin per internode. Few tens of molecules would increase the myelin conductance with a dramatic consequence on the amplitude decay as shown in C. E, Action potential triggered by a sustained 250 ms pulse of 2 nA, as shown above, at a control condition with a conductance, 2 × 10−5 S/cm2. F, In blue, action potentials triggered at a conduction of 5 × 10−5 S/cm2, the frequency of firing is decreased. G, In red, action potentials triggered at a conduction of 2 × 10−4 S/cm2, the frequency decreases until no action potentials can be elicited. H, Plot of the calculated number of action potentials triggered versus myelin conductance. Code color as C, D. As the conductance of myelin increases, the number of action potentials elicited is decreased.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Electron microscopy of compact myelin from optic nerves. Electron microscopy images of myelin in (A) control conditions and (B) toxin conditions. Scale bar is represented in every panel. C, Magnification over myelin layers to quantify distance on major lines. Contrast and brightness were modified to enhance the dense line of the myelin. Yellow bar (20 nm) represents the line through which the gray intensity was measured. D, Graphic representation of gray intensity (black line) measured in C. A sinusoidal function was fitted to calculate the distance between peaks (red dashed line); the distance between the dense lines was estimated after applying a Fourier transform. E, The mean distance between major lines in control (blue; 30 images analyzed, n = 2 mice) and toxin (red; 30 images analyzed, n = 3 mice) conditions. No significant difference was found between the both means (p = 0.9062). Mean values ± SEM represented.

Tables

  • Figures
    • View popup
    Table 1.

    Statistical significance for amplitude peak fractional decrease

    PointData structureType of testPowerSignificance
    t-5 vs t50
    1NormalPaired two-tailed t test0
    2NormalPaired two-tailed t test0.0405*
    3NormalPaired two-tailed t test0.0107**
    4NormalPaired two-tailed t test0.0072**
    5NormalPaired two-tailed t test0.0094**
    6NormalPaired two-tailed t test0.0155*
    7NormalPaired two-tailed t test0.0304*
    8NormalPaired two-tailed t test0.0097**
    9NormalPaired two-tailed t test0.0824
    10NormalPaired two-tailed t test0.0103*
    11NormalPaired two-tailed t test0.0571
    12NormalPaired two-tailed t test0.0209*
    13NormalPaired two-tailed t test0.0744
    14NormalPaired two-tailed t test0.0279*
    t-5 vs t80
    21NormalPaired two-tailed t test0
    22NormalPaired two-tailed t test0.0188*
    23NormalPaired two-tailed t test0.007**
    24NormalPaired two-tailed t test0.0064**
    25NormalPaired two-tailed t test0.0202*
    26NormalPaired two-tailed t test0.0306*
    27NormalPaired two-tailed t test0.0322*
    28NormalPaired two-tailed t test0.0284*
    29NormalPaired two-tailed t test0.0673
    30NormalPaired two-tailed t test0.0418*
    31NormalPaired two-tailed t test0.0522
    32NormalPaired two-tailed t test0.0457*
    33NormalPaired two-tailed t test0.0693
    34NormalPaired two-tailed t test0.0551
    35NormalPaired two-tailed t test0.0866
    36NormalPaired two-tailed t test0.0682
    37NormalPaired two-tailed t test0.084
    38NormalPaired two-tailed t test0.0872
    39NormalPaired two-tailed t test0.0927
    • Significance power of statistical analysis of paired two-tailed t test of the peak amplitude, comparing the first peak of the 100-Hz train stimulation to the rest 18 peaks. *p < 0.05; **p < 0.01. (N = 7 control, 11 toxin).

    • View popup
    Table 2.

    Statistical significance for area peak fractional decrease

    PointData structureType of testPowerSignificance
    t-5 vs t50
    41NormalPaired two-tailed t test0
    42NormalPaired two-tailed t test0.0123*
    43NormalPaired two-tailed t test0.0482*
    44NormalPaired two-tailed t test0.0518
    45NormalPaired two-tailed t test0.0304*
    46NormalPaired two-tailed t test0.014*
    47NormalPaired two-tailed t test0.0142*
    48NormalPaired two-tailed t test0.0187*
    49NormalPaired two-tailed t test0.0207*
    50NormalPaired two-tailed t test0.0293*
    51NormalPaired two-tailed t test0.0921
    52NormalPaired two-tailed t test0.1104
    53NormalPaired two-tailed t test0.0437*
    54NormalPaired two-tailed t test0.0442*
    55NormalPaired two-tailed t test0.0275*
    56NormalPaired two-tailed t test0.0309*
    57NormalPaired two-tailed t test0.0327*
    58NormalPaired two-tailed t test0.0254*
    59NormalPaired two-tailed t test0.0304*
    t-5 vs t80
    61NormalPaired two-tailed t test0
    62NormalPaired two-tailed t test0.055
    63NormalPaired two-tailed t test0.0579
    64NormalPaired two-tailed t test0.0435*
    65NormalPaired two-tailed t test0.0276*
    66NormalPaired two-tailed t test0.0223*
    67NormalPaired two-tailed t test0.0348*
    68NormalPaired two-tailed t test0.0362*
    • Significance power of statistical analysis of paired two-tailed t test of the peak area, comparing the first peak of the 100 Hz train stimulation to the rest 18 peaks. *p < 0.05. (N = 7 control, 11 toxin).

Back to top

In this issue

eneuro: 4 (4)
eNeuro
Vol. 4, Issue 4
July/August 2017
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Acute Effect of Pore-Forming Clostridium perfringens ε-Toxin on Compound Action Potentials of Optic Nerve of Mouse
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Acute Effect of Pore-Forming Clostridium perfringens ε-Toxin on Compound Action Potentials of Optic Nerve of Mouse
Mercè Cases, Artur Llobet, Beatrice Terni, Inmaculada Gómez de Aranda, Marta Blanch, Briain Doohan, Alexander Revill, Angus M. Brown, Juan Blasi, Carles Solsona
eNeuro 31 July 2017, 4 (4) ENEURO.0051-17.2017; DOI: 10.1523/ENEURO.0051-17.2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Acute Effect of Pore-Forming Clostridium perfringens ε-Toxin on Compound Action Potentials of Optic Nerve of Mouse
Mercè Cases, Artur Llobet, Beatrice Terni, Inmaculada Gómez de Aranda, Marta Blanch, Briain Doohan, Alexander Revill, Angus M. Brown, Juan Blasi, Carles Solsona
eNeuro 31 July 2017, 4 (4) ENEURO.0051-17.2017; DOI: 10.1523/ENEURO.0051-17.2017
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • action potential
  • atp release
  • clostridial toxin
  • electrophysiology
  • myelin
  • optic nerve

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Neuronal Excitability

  • Intrinsic cell-class-specific modulation of intracellular chloride levels and inhibitory function, in cortical networks, between day and night.
  • Individual Variation in Intrinsic Neuronal Properties of Nucleus Accumbens Core and Shell Medium Spiny Neurons in Male Rats Prone to Sign- or Goal-Track
  • Multiplexed smFISH reveals the spatial organization of neuropil localized mRNAs is linked to abundance
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.